Skip to main content
. 2024 Feb 21;10(5):e26774. doi: 10.1016/j.heliyon.2024.e26774

Table 1.

Serum concentrations of CCL20 and AFP.

Markers Control group
Benign disease group
HCC group
Stage I
Stage II
Stage III
Stage IV
Median IQR Median IQR Median IQR Median IQR Median IQR Median IQR Median IQR
CCL20 7.57 1.45–34.67 17.10 7.71–70.38 33.80 3.86–615.68 26.87 10.47–103.50 18.73 8.15–132.17 31.3 24.24–119.10 57.15 22.74–174.63
AFP 2.50 1.98–3 2.70 2.10–5.70 352.15 13.18–3000 49.70 10.05–3000 629.00 12.8–3000 1168.8 44.68–3000 98.5 8.61–1563.6